BK
Bhoopendra Singh Kushwah
Syngene International (India), Aurigene Discovery Technologies (India), National Institute of Pharmaceutical Education and Research
Employment
-
Syngene International (India) Research Investigator2022 - Present
-
Aurigene Discovery Technologies (India)2016 - 2017
Education
-
National Institute of Pharmaceutical Education and Research Ph.D2017 - 2022
-
National Institute of Pharmaceutical Education and Research M.S. (Pharm.)2014 - 2016
Projects & Funding
Projects & funding information is unavailable.
Publications (20)
- First Method for Trace-Level Quantification of the Potential Genotoxic Impurity Bis(neopentyl glycolato)diboron Using GC–MS Save
- Multi-method coamorphous systems of lumefantrine with alpha ketoglutaric acid: Comprehensive characterization, biological evaluation and stability analysis Save
- Analytical Artifact Due to Residual HCN in Acetonitrile: Identification and Control Strategies Save
- Analytical Strategy for Low-Level Estimation of Unstable Genotoxic Boronate Ester Impurities Save
- In vivo and in vitro metabolite profiling of nirmatrelvir using LC–Q‐ToF–MS/MS along with the in silico approaches for prediction of metabolites and their toxicity Save
- Chromatographic separation of tiropramide hydrochloride and its degradation products along with their structural characterization using liquid chromatography quadrupole time‐of‐flight tandem mass spectrometry and nuclear magnetic resonance Save
- LC-HRMS and NMR studies for characterization of forced degradation impurities of ponatinib, a tyrosine kinase inhibitor, insights into in-silico degradation and toxicity profiles Save
- Characterization of potential degradation products of brexpiprazole by liquid chromatography/quadrupole–time‐of‐flight mass spectrometry and nuclear magnetic resonance, and prediction of their physicochemical properties by ADMET Predictor™ Save
- Development of stability‐indicating method for separation and characterization of benidipine forced degradation products using LC–MS/MS Save
- Structural characterization of novel hydrolytic and oxidative degradation products of acalabrutinib by LC-Q-TOF-MS, H/D exchange and NMR Save